Unicorn Capital Partners
独秀资本
Unicorn Capital Partners (独秀资本) is a China-focused venture fund whose deal record shows it led the Series B+ round for domestic cloud-based UI design tool Js.Design in 2022 , and more recently joined a follow-on financing for Ze'an Biopharmaceutical alongside 5Y Capital, BlueRun Ventures and others in 2026 . elsewhere's corpus does not cover its founding date, team composition, or fund size — the retrieved material only captures these two disclosed investments.
AI-generated — may contain errors, please verify.
Coverage
BlueRun Ventures Portfolio Company NeoImmuneTech Completes $38 Million Financing to Advance First-in-Class "Myeloid Cell Engager" Immunotherapy Pipeline | BlueRun Family
From Technical Platform Validation to Clinical Value
Zean completes $40 million Series A+ round to accelerate development of myeloid cell engager pipeline | BlueRun Ventures Family
Focusing on unmet clinical needs in major disease areas such as cancer and autoimmune diseases.
From PhD to "Foreman": Building a Robot Bricklayer, Paid for by Middle Eastern Tycoons | Linear Capital Portfolio Company
One robot replaces ten skilled workers, with efficiency up 14-fold
BlueRun Ventures June Report | Hope Is a Sweet Waiting
Looking out from a bountiful June
"Jishi Design" Closes Tens of Millions of Dollars in Series B+ Funding, User Base Surpasses One Million | BlueRun Ventures
Achieved million-scale user growth, supporting the development of China's open-source design community.
